Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Nico Riffel has worked on the following 4 EPO patent applications which have been published in the last five years:

EP13722415

METHODS FOR THE ACTIVATION OF SILENT GENES IN A MICROORGANISM

IPC classification:
C12N 1/14, C12N 1/20, C12N 1/38, C12P 1/00, C12Q 1/02, C12R 1/01, C12R 1/645
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP13722414

METHOD FOR PRODUCING RECOMBINANT 11-DE-O-METHYLTOMAYMYCIN

IPC classification:
A61K 31/445, C07D 519/00
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP14306740

21-Hydroxylation of steroids

IPC classification:
C12P 33/06
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP15306106

FUSION MOLECULES

IPC classification:
C07K 14/47
Applicant:
Sanofi, S.A.
Agent:
Nico Riffel, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED

Please Sign in to use this feature